FMC CEO awarded 29 shares via dividend rights
BRONDEAU PIERRE R reported acquisition or exercise transactions in this Form 4 filing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
BRONDEAU PIERRE R reported acquisition or exercise transactions in this Form 4 filing.
FMC CORP Chairman, CEO and President Pierre R. Brondeau received a grant of 29 shares of Common Stock on April 16, 2026. The shares were issued at no cost through dividend equivalent rights tied to vested restricted stock units. Following this award, he directly holds 568,046 FMC shares, reflecting routine equity-based executive compensation rather than an open-market purchase or sale.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 29 | $0.00 | $0.00 |
Footnotes (1)
- F1. These shares were issued pursuant to dividend equivalent rights in connection with vested restricted stock units held by the reporting person.
Key Figures
Key Terms
dividend equivalent rights financial
restricted stock units financial
Form 4 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did FMC (FMC) report for Pierre R. Brondeau?
Was the FMC (FMC) Form 4 transaction a stock purchase or sale?
What are dividend equivalent rights in the FMC (FMC) insider filing?
What does transaction code "A" mean in the FMC (FMC) Form 4?
AI-generated analysis. How Rhea-AI works. Not financial advice.